Analysis of Protein and Emotional Alterations During and After Hypobaric Hypoxia (DRU-EMO-K)

May 16, 2022 updated by: Jochen Hinkelbein, Universitätsklinikum Köln
This study analyses both Protein Expression and emotional alterations during hypobaric hypoxia in volunteers of different groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study analyses both Protein Expression and emotional alterations during hypobaric hypoxia in volunteers of different groups.

15 different Groups are analysed: control Group, 5000ft Group, 8000 ft Group, 10000ft Group and 15000ft Group - all for 15, 30, and 60 minutes.

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • NRW
      • Cologne, NRW, Germany, 50937
        • University Hospital of Cologne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Helathy

Exclusion Criteria:

  • Ear problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: control group 15

Protein expression and emotional test

15 minutes normoxia

Interventions:

Blood drawing 1 Minute before and 1 Minute after the pressure chamber Phase for Proteomic profiling with 2D-gels

Emotional tests (tears, stroop, mood) during the pressure chamber phase

NO_INTERVENTION: control group 30

30 minutes normoxia

Interventions:

Blood drawing 1 Minute before and 1 Minute after the pressure chamber Phase for Proteomic profiling with 2D-gels

Emotional tests (tears, stroop, mood) during the pressure chamber phase

NO_INTERVENTION: control group 60

60 minutes normoxia

Interventions:

Blood drawing 1 Minute before and 1 Minute after the pressure chamber Phase for Proteomic profiling with 2D-gels

Emotional tests (tears, stroop, mood) during the pressure chamber phase

EXPERIMENTAL: hypoxia 5000ft group 15
Intervention: 15 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 5000ft group 30
Intervention: 30 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 5000ft group 60
Intervention: 60 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 8000ft group 15
Intervention: 15 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 8000ft group 30
Intervention: 30 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 8000ft group 60
Intervention: 60 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 10000ft group 15
Intervention: 15 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 10000ft group 30
Intervention: 30 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 10000ft group 60
Intervention: 60 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 15000ft group 15
Intervention: 15 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 15000ft group 30
Intervention: 30 minutes hypoxia
hypoxia
EXPERIMENTAL: hypoxia 15000ft group 60
Intervention: 60 minutes hypoxia
hypoxia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein Expression before hypoxia
Time Frame: Measurement immediately 1 minute before of hypoxia/experiment
proteomic profiling of Serum by 2D-gels. All Proteins present in the sample will be identified by proteomics
Measurement immediately 1 minute before of hypoxia/experiment
Protein Expression after hypoxia
Time Frame: Measurement immediately and at termination (i.e., 1 minute after) of hypoxia/experiment
proteomic profiling of Serum by 2D-gels. All Proteins present in the sample will be identified by proteomics
Measurement immediately and at termination (i.e., 1 minute after) of hypoxia/experiment
Emotional assessment tears
Time Frame: Measurement starts immediately with hypoxia in the pressure chamber. duration 10 minutes
Emotional tears test
Measurement starts immediately with hypoxia in the pressure chamber. duration 10 minutes
Emotional assessment
Time Frame: Measurement in the pressure chamber after tears test (i.e. 10 minutes after start). duration 10 minutes
Emotional stroop test; Williams, J. M. G., Mathews, A., & MacLeod, C. (1996). The emotional Stroop task and psychopathology. Psychological Bulletin, 120, 3-24.
Measurement in the pressure chamber after tears test (i.e. 10 minutes after start). duration 10 minutes
Emotional assessment mood
Time Frame: Measurement in the pressure chamber after stroop test (i.e. 20 minutes after start). duration 10 minutes
Emotional mood test, POMS mood score. Shukitt-Hale, B., Banderet, L.E., & Lieberman, H.R. (1998). Elevation-dependent symptom, mood, and performance changes produced by exposure to hypobaric hypoxia, The International Journal of Aviation Psychology, 8, 319-334,
Measurement in the pressure chamber after stroop test (i.e. 20 minutes after start). duration 10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jochen Hinkelbein, University Hospital of Cologne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2018

Primary Completion (ACTUAL)

April 30, 2022

Study Completion (ACTUAL)

April 30, 2022

Study Registration Dates

First Submitted

January 7, 2019

First Submitted That Met QC Criteria

January 29, 2019

First Posted (ACTUAL)

January 30, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • DRU-EMO-KOELN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoxia, Altitude

Clinical Trials on Hypoxia

3
Subscribe